Related Experiment Videos
Platelet transfusion tolerization by liver membrane treatment.
Transplantation
|August 1, 1979
Summary
Researchers developed a new murine model to prevent sensitization to allogeneic platelet transfusions. Allogeneic liver membrane treatment successfully induced tolerance to major histocompatibility alloantigens, ensuring normal platelet survival.
Area of Science:
- Immunology
- Transplantation Biology
- Hematology
Background:
- Sensitization to allogeneic platelet transfusions is a significant clinical challenge.
- Existing models for studying platelet alloimmunization have limitations.
Purpose of the Study:
- To develop a nontoxic murine model for preventing sensitization to allogeneic platelet transfusions.
- To investigate the efficacy of allogeneic liver membrane (LM) in inducing tolerance to major histocompatibility alloantigens.
Main Methods:
- Established a murine model using C3H and C57BL mouse strains.
- Assessed platelet survival (t1/2) following syngeneic and allogeneic transfusions.
- Administered allogeneic liver membranes (LM) concomitantly with allogeneic lymphoid cells to induce tolerance.
Main Results:
- Normal platelet survival varied between mouse strains, indicating genetic determination.
- Passive immunization decreased platelet survival.
- Concomitant LM treatment with allogeneic cells blocked sensitization and maintained normal allogeneic platelet survival.
Conclusions:
- Allogeneic liver membrane treatment is a safe and effective method for preventing adult sensitization to allogeneic platelets.
- This murine model provides a valuable tool for studying platelet alloimmunization and tolerance induction.